Prevention of catheter-related bacteremia in children on hemodialysis: Time for action

Pediatric Nephrology

Volumn 24, Issue 11, 2009, Pages 2087-2095

  Stefanidis, Constantinos J ^a  

^a P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

Author keywords

Catheter related bacteremia; Children; Hemodialysis; Intraluminal antimicrobial lock; Vascular access

Indexed keywords

AMIKACIN; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CITRATE TRISODIUM; EDETIC ACID; GENTAMICIN; HEPARIN; MINOCYCLINE; PSEUDOMONIC ACID; TAUROLIDINE; TISSUE PLASMINOGEN ACTIVATOR; TOBRAMYCIN; VANCOMYCIN;

ATAXIA; BACTEREMIA; BACTERIUM CONTAMINATION; BIOFILM; BLEEDING; BLOOD CULTURE; CATHETER INFECTION; CATHETER REMOVAL; CATHETERIZATION; CHILD; CLINICAL TRIAL; DIZZINESS; DOSE RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDITORIAL; EPIDEMIOLOGICAL DATA; HEARING IMPAIRMENT; HEMODIALYSIS; HUMAN; HYPOCALCEMIA; INFECTION PREVENTION; INFECTION RISK; LOW DRUG DOSE; OTOTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT INFECTION; VASCULAR ACCESS;

BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; DISINFECTION; EQUIPMENT CONTAMINATION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RENAL DIALYSIS; RISK FACTORS;

EID: 70349731558     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1254-2     Document Type: Editorial

References (84)

1. Fischbach M, Edefonti A, Schröder C, Watson A, The European Pediatric Dialysis Working Group (2005) Hemodialysis in children: general practical guidelines. Pediatr Nephrol 20:1054-1066
2. Fadrowski JJ, Hwang W, Neu AM, Fivush BA, Furth SL (2009) Patterns of use of vascular catheters for hemodialysis in children in the United States. Am J Kidney Dis 53:91-98
3. Mahan JD Jr, Mauer SM, Nevins TE (1983) The Hickman catheter: A new hemodialysis access derice for infants and small children. Kidney Int 24:694-697
4. Onder AM, Chandar J, Billings AA, Simon N, Gonzalez J, Francoeur D, Abitbol C, Zilleruelo G (2009) Prophylaxis of catheter-related bacteremia using tissue plasminogen activator- tobramycin locks. Pediatr Nephrol. doi: 10.1007/s00467-009-1235-5
5. Fadrowski JJ, Hwang W, Frankenfield DL, Fivush BA, Neu AM, Furth SL (2006) Clinical course associated with vascular access type in a national cohort of adolescents who receive hemodialysis: Findings from the Clinical Performance Measures and US Renal Data System projects. Clin J Am Soc Nephrol 1:987-992
6. Lemaire X, Morena M, Leray-Moragués H, Henriet-Viprey D, Chenine L, Defez-Fougeron C, Canaud B (2009) Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis. Blood Purif 28:21-28
7. North American Pediatric Renal Transplant Cooperative Study (2008) Annual Report. Renal transplantation, dialysis, chronic renal insufficiency. Available at: https://web.emmes.com/study/ped/annlrept/ Annual Report-2008.pdf
8. Chavers BM, Solid CA, Gilbertson DT, Collins AJ (2007) Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States. J Am Soc Nephrol 18:952-959
9. Centers for Disease Control and Prevention (2000) Monitoring hospital acquired infections to promote patient safety - United States, 1990-1999. MMWR Morb Mortal Wkly Rep 49:149-153
10. Saxena AK, Panhorota BR, Al-Mulhim AS (2005) Vascular access related infections in hemodialysis patients. Saudi J Kidney Dis Transplant 16:46-71
11. Beathard GA (2003) Catheter management protocol for catheter-related bacteremia prophylaxis. Semin Dial 16:403-405
12. Hannah EL, Stevenson KB, Lowder CA, Adcox MJ, Davidson RL, Mallea MC, Narasimhan N, Wagnild JP (2002) Outbreak of hemodialysis vascular access site infections related to malfunctioning permanent tunneled catheters: making the case for active infection surveillance. Infect Control Hosp Epidemiol 23:538-541
13. George A, Tokars JI, Clutterbuck EJ, Bamford KB, Pusey C, Holmes AH (2006) Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: Prospective study. BMJ 17 332:1435
14. Klevens RM, Tokars JI, Andrus M (2005) Electronic reporting of infections associated with hemodialysis. Nephrol News Issues 19:37-38
15. Beathard GA, Urbanes A (2008) Infection associated with tunneled hemodialysis catheters. Semin Dial 21:528-538
16. Trautner B, Darouiche R (2004) Catheter-associated infections. Arch Intern Med 164:842-850
17. Crnich CJ, Maki DG (2002) The promise of novel technology for the prevention of intravascular device-related bloodstream infection, I: Pathogenesis and short-term devices. Clin Infect Dis 34:1232-1342
18. Suojanen JN, Brophy DP, Nasser I (2000) Thrombus on indwelling central venous catheters: The histopathology of "fibrin sheaths". Cardiovasc Intervent Radiol 23:194-197
19. Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2:95-108
20. Donlan RM (2002) Biofilms microbial life on surfaces. Emerg Infect Dis 9:881-890
21. Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G (2003) The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 112:1466-1477
22. Marrie TJ, Costerton JW (1984) Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters. J Clin Microbiol 19:687-693
23. Ward KH, Olson ME, Lam K, Costerton JW (1992) Mechanism of persistent infection associated with peritoneal implants. J Med Microbiol 36:406-413
24. Rijnders BJ, Van Wijngaerden E, Van Eldere J, Peetermans WE (2001) Polyclonal Staphylococcus epidermidis intravascular catheter related infections. Clin Microbiol Infect 7:388-391
25. Allon M (2004) Dialysis catheter-related bacteremia: Treatment and prophylaxis. Am J Kidney Dis 4:779-791
26. Mokrzycki MH, Zhang M, Cohen H, Golestaneh L, Laut JM, Rosenberg SO (2006) Tunnelled hemodialysis catheter bacteraemia: Risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant 21:1024-1031
27. Jaber BL (2005) Bacterial infections in hemodialysis patients: pathogenesis and prevention. Kidney Int 67:2508-2519
28. Tanriover B, Carlton D, Saddekni S, Hamrick K, Oser R, Westfall AO, Allon M (2000) Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies. Kidney Int 57:2151-2155
29. Canaud B, Sénécal L, Leray-Moragués H, Picard-Gontiers A, Terrier N, Morena M, Cristol JP (2003) Vascular access, an underestimated cause of inflammation in hemodialysis patient. Néphrologie 24:353-358
30. Mermel LA, Farr BM, Sherertz RJ, Issam I, Raad II, O'Grady N, Harris JS, Craven DE (2001) Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32:1249-1272
31. DesJardin J (1999) Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Ann Intern Med 131:641-647
32. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB (1997) Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 127:275-280
33. Saad TF (1999) Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 34:1114-1124
34. Allon M (2005) Saving infected catheters: Why and how. Blood Purif 23:23-28
35. Robinson D, Suhocki P, Schwab SJ (1998) Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange. Kidney Int 53:1792-1794
36. Onder AM, Chandar J, Saint-Vil M, Lopez-Mitnik G, Abitbol CL, Zilleruelo G (2007) Catheter survival and comparison of catheter exchange methods in children on hemodialysis. Pediatr Nephrol 22:1355-1361
37. Messing B, Peitra-Cohen S, Beliah M, Bernier J (1988) Antibiotic- lock technique: An approach to optimal therapy for catheter-related sepsis in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 12(2):185-189
38. Manierski C, Besarab A (2006) Antimicrobial locks: Putting the lock on catheter infections. Adv Chronic Kidney Dis 13:245-258
39. Capdevila JA, Segarra A, Planes AM, Ramírez-Arellano M, Pahissa A, Piera L, Martínez-Vázquez JM (1993) Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant 8:231-234
40. Krishnasami Z, Carlton D, Bimbo L, Taylor ME, Balkovetz DF, Barker J, Allon M (2002) Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 61:1136-1142
41. Vardhan A, Davies J, Daryanani I, Crowe A, McClelland P (2002) Treatment of haemodialysis catheter-related infections. Nephrol Dial Transplant 17:1149-1150
42. Poole CV, Carolton D, Bimbo L, Allon M (2004) Treatment of catheter-related bacteraemia with an antibiotic lock protocol: Effect of bacterial pathogen. Nephrol Dial Transplant 19:1237-1244
43. Allon M (2003) Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 36:1539-1544
44. Onder AM, Chandar J, Billings AA, Simon N, Diaz R, Francoeur D, Abitbol C, Zilleruelo G (2008) Comparison of early versus late use of antibiotic locks in the treatment of catheter-related bacteremia. Clin J Am Soc Nephrol 3:1048-1056
45. Onder AM, Chandar J, Simon N, Saint-Vil M, Francoeur D, Nwobi O, Abitbol C, Zilleruelo G (2008) Treatment of catheter-related bacteremia with tissue plasminogen activator antibiotic locks. Pediatr Nephrol 23:457-464
46. Mokrzycki MH (2008) Use of prophylactic topical or intraluminal antibiotics for hemodialysis catheters. Nat Clin Pract Nephrol 4:478-479
47. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA (2002) Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 51:1-29
48. Maki DG, Goldman DA, Rhame FS (1973) Infection control in intravenous therapy. Ann Intern Med 79:867-887
49. National Kidney Foundation: K/DOQI Guidelines. Clinical practice guidelines for vascular access, 2006 update. Available at www.kidney.org
50. Rubinson L, Wu AW, Haponik EE, Diette GB (2005) Why is it that internists do not follow guidelines for preventing intravascular catheter infections? Infect Control Hosp Epidemiol 26:525-533
51. Stevenson KB, Hannah EL, Lowder CA (2002) Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data. Predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 39:549-555
52. Weijmer MC, Vervloet MG, ter Wee PM (2004) Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol Dial Transplant 19:670-677
53. Johnson DW, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, Hollett P (2002) A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 17:1802-1807
54. Cookson BD (1990) Mupirocin resistance in staphylococci. J Antimicrob Chemother 25:497-501
55. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J (2003) Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 13:169-179
56. Boelaert JR, Van Landuyt HW, Godard CA, Daneels RF, Schurgers ML, Matthys EG, De Baere YA, Gheyle DW, Gordts BZ, Herwaldt LA (1993) Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol Dial Transplant 8:235-239
57. Shanks RM, Donegan NP, Graber ML, Buckingham SE, Zegans ME, Cheung AL, O'Toole GA (2005) Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun 73:4596-4606
58. Moritz ML, Vats A, Ellis D (2003) Systemic anticoagulation and bleeding in children with hemodialysis catheters. Pediatr Nephrol 18:68-70
59. Polaschegg HD, Shah C (2003) Overspill of catheter locking solution: safety and efficacy aspects. ASAIO J 49:713-715
60. Sungur M, Eryuksel E, Yavas S, Bihorac A, Layon AJ, Caruso L (2007) Exit of catheter lock solutions from double lumen acute haemodialysis catheters an in vitro study. Nephrol Dial Transplant 22:3533-3537
61. Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, Siegert CE, Stas KJ, CITRATE Study Group (2005) Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16:2769-2777
62. US Food and Drug Administration (2000) FDA issues warning on tricitrasol dialysis catheter anticoagulant. FDA talk paper TOO-16, April 14
63. MacRae JM, Dojcinovic I, Djurdjev O, Jung B, Shalansky S, Levin A, Kiaii M (2008) Citrate 4% versus Heparin and the Reduction of Thrombosis Study (CHARTS). Clin J Am Soc Nephrol 3:369-374
64. Grudzinski L, Quinan P, Kwok S, Pierratos A (2007) Sodium citrate 4% locking solution for central venous hemodialysis catheters-an effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant 22:471-476
65. Traub WH, Leonhard B, Bauer D (1993) Taurolidine: In vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae. Chemotherapy 39:322-330
66. Betjes MG, van Agteren M (2004) Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 19:1546-1551
67. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, Luxton G, Moody H (2002) Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: A randomized controlled study. J Am Soc Nephrol 13:2133-2139
68. Saxena AK, Panhotra BR, Naguib M (2002) Sudden irreversible sensory-neural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-heparin lock. Pharmacotherapy 22:105-108
69. McIntyre CW, Hulme LJ, Taal M (2004) Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 66:801-805
70. Cooper R, Saad T (1999) Prevention of bacteraemia in patients with tunnelled cuffed "permanent" hemodialysis catheters (PCs) using gentamicin catheter packing. J Am Soc Nephrol 10:203A
71. Zhang P, Zhang W, He Q, Yuan J, Xie W, Jiang W, Jiang H, Chen J (2006) A randomized controlled study on prevention of cuff-tunneled catheter related bacteremia with gentamicin-heparin lock solution: The metaphase result [abstract]. J Am Soc Nephrol 17:592A
72. Pervez A, Ahmed M, Ram S, Torres C, Work J, Zaman F, Abreo K (2002) Antibiotic lock technique for prevention of cuffed tunnel catheter associated bacteremia. J Vasc Access 3:108-113
73. Al-Hwiesh AK, Abdul-Rahman IS (2007) Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using vancomycin and gentamycin. Saudi J Kidney Dis Transpl 18:239-247
74. Kim SH, Song KI, Chang JW (2006) Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: A prospective, randomized clinical trial. Kidney Int 69:161-164
75. Saxena AK, Panhotra BR (2005) The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: A case controlled study. J Nephrol 18:755-763
76. Saxena AK, Panhotra BR, Sundaram DS, Morsy MN, Al-Ghamdi AM (2006) Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: A randomised, double-blind clinical trial. Nephrology (Carlton) 11:299-305
77. Nori US, Manoharan A, Yee J, Besarab A (2006) Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 48:596-605
78. Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ (2005) A randomized, controlled trial of a new vascular catheter flush solution (minocycline- EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 26:520-524
79. James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR, Alberta Kidney Disease Network (2008) Meta-analysis: Antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med 148:596-605
80. Labriola L, Crott R, Jadoul M (2008) Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: A meta-analysis of prospective randomized trials. Nephrol Dial Transplant 23:1666-1672
81. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M (2008) Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: Systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 47:83-93
82. Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW (2008) A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis 51:233-241
83. Guerraoui AA, Dacosta EE, Roche BB (2004) Emergence of multiresistant Staphylococcus epidermidis (MRSE) after lock antibiotic regimen by gentamicin in permanent hemodialysis catheters. Prospective study, 1999-2003 [abstract]. J Am Soc Nephrol 15:368A
84. Bleyer AJ (2007) Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia. Clin J Am Soc Nephrol 2:1073-1078